These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34122607)

  • 1.
    Lei SS; Zhang NY; Zhou FC; He X; Wang HY; Li LZ; Zheng X; Dong YJ; Luo R; Li B; Jin HY; Yu QX; Lv GY; Chen SH
    Evid Based Complement Alternat Med; 2021; 2021():6689727. PubMed ID: 34122607
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of
    Shi ML; Yan MQ; Su J; Yu JJ; Ye SY; Fu M; Hu XL; Niu ZW; Wu WY; Chen SM; Chen SH; Chen JZ; Lv GY
    Food Funct; 2022 Nov; 13(23):12436-12450. PubMed ID: 36377633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brown Rice Inhibits Development of Nonalcoholic Fatty Liver Disease in Obese Zucker (fa/fa) Rats by Increasing Lipid Oxidation Via Activation of Retinoic Acid Synthesis.
    Matsumoto Y; Fujita S; Yamagishi A; Shirai T; Maeda Y; Suzuki T; Kobayashi KI; Inoue J; Yamamoto Y
    J Nutr; 2021 Sep; 151(9):2705-2713. PubMed ID: 34224565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of Dendrobium officinale on metabolic hypertensive rats by triggering the enteric-origin SCFA-GPCR43/41 pathway.
    Li B; He X; Jin HY; Wang HY; Zhou FC; Zhang NY; Jie DY; Li LZ; Su J; Zheng X; Luo R; Lv GY; Jiang NH; Yu QX; Chen SH
    Food Funct; 2021 Jun; 12(12):5524-5538. PubMed ID: 34002173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice.
    Dong Y; Lu H; Li Q; Qi X; Li Y; Zhang Z; Chen J; Ren J
    Life Sci; 2019 Sep; 232():116644. PubMed ID: 31301418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.
    Nagaya T; Tanaka N; Kimura T; Kitabatake H; Fujimori N; Komatsu M; Horiuchi A; Yamaura T; Umemura T; Sano K; Gonzalez FJ; Aoyama T; Tanaka E
    BBA Clin; 2015 Jun; 3():168-74. PubMed ID: 26674248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow-Release H
    Zhao C; Yu N; Li W; Cai H; Liu M; Hu Y; Liu Y; Tang M
    Front Pharmacol; 2020; 11():549377. PubMed ID: 33071780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
    Serviddio G; Bellanti F; Vendemiale G
    Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α.
    Liu T; Luo X; Li ZH; Wu JC; Luo SZ; Xu MY
    World J Gastroenterol; 2019 Sep; 25(36):5451-5468. PubMed ID: 31576092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary eicosapentaenoic acid supplementation accentuates hepatic triglyceride accumulation in mice with impaired fatty acid oxidation capacity.
    Du ZY; Ma T; Liaset B; Keenan AH; Araujo P; Lock EJ; Demizieux L; Degrace P; Frøyland L; Kristiansen K; Madsen L
    Biochim Biophys Acta; 2013 Feb; 1831(2):291-9. PubMed ID: 23085008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.
    Yamada K; Mizukoshi E; Sunagozaka H; Arai K; Yamashita T; Takeshita Y; Misu H; Takamura T; Kitamura S; Zen Y; Nakanuma Y; Honda M; Kaneko S
    Liver Int; 2015 Feb; 35(2):582-90. PubMed ID: 25219574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of fatty acid composition and lipid storage by thyroid hormone in mouse liver.
    Yao X; Hou S; Zhang D; Xia H; Wang YC; Jiang J; Yin H; Ying H
    Cell Biosci; 2014; 4():38. PubMed ID: 25105012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertensive Rats Treated Chronically With N
    Li B; He X; Lei SS; Zhou FC; Zhang NY; Chen YH; Wang YZ; Su J; Yu JJ; Li LZ; Zheng X; Luo R; Kołodyńska D; Xiong S; Lv GY; Chen SH
    Front Pharmacol; 2019; 10():1677. PubMed ID: 32076406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the modulation of fructose/sucrose-induced hepatic steatosis by mixed lipid formulations varying in unsaturated fatty acid content.
    Siddiqui RA; Xu Z; Harvey KA; Pavlina TM; Becker MJ; Zaloga GP
    Nutr Metab (Lond); 2015; 12():41. PubMed ID: 26583036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome Analysis Reveals Differential Expression of Genes Regulating Hepatic Triglyceride Metabolism in Pekin Ducks During Dietary Threonine Deficiency.
    Jiang Y; Xie M; Fan W; Xue J; Zhou Z; Tang J; Chen G; Hou S
    Front Genet; 2019; 10():710. PubMed ID: 31428138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.